Conmed (CNMD) Total Non-Current Liabilities (2010 - 2026)

Conmed has reported Total Non-Current Liabilities for 17 years, with the latest figure at $1.2 billion in Q1 2026.

• For the quarter ending Q1 2026, Total Non-Current Liabilities fell 0.83% year-over-year to $1.2 billion; the trailing twelve-month figure through Mar 2026 stood at $1.2 billion (down 0.83% YoY), and the FY2025 full-year result was $1.2 billion, down 2.26% from the prior year.
• Total Non-Current Liabilities for Q1 2026 stood at $1.2 billion, roughly flat from $1.2 billion in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $1.4 billion in Q2 2023, with the low at $954.4 million in Q1 2022.
• Historically, Total Non-Current Liabilities has averaged $1.3 billion across 5 years, with a median of $1.3 billion in 2022.
• Annual changes were most pronounced in 2023 — Total Non-Current Liabilities soared 44.76% — and 2025, when it retreated 7.5%.
• Conmed's Total Non-Current Liabilities stood at $1.3 billion in 2022, then decreased by 0.27% to $1.3 billion in 2023, then dropped by 6.51% to $1.3 billion in 2024, then slipped by 2.26% to $1.2 billion in 2025, then climbed by 0.44% to $1.2 billion in 2026.
• The last three Total Non-Current Liabilities figures came in at $1.2 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.2 billion (Q3 2025), per Business Quant data.